Cargando…

Isobologram analysis of triple therapies

New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases. Similar to conventional anti-cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Niyazi, Maximilian, Belka, Claus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634864/
https://www.ncbi.nlm.nih.gov/pubmed/17044920
http://dx.doi.org/10.1186/1748-717X-1-39
_version_ 1782130650445250560
author Niyazi, Maximilian
Belka, Claus
author_facet Niyazi, Maximilian
Belka, Claus
author_sort Niyazi, Maximilian
collection PubMed
description New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases. Similar to conventional anti-cancer agents, the efficacy of targeted approaches is also subject to predefined resistance mechanisms. Therefore, it seems reasonable to speculate that a combination of more than two agents will ultimately increase the therapeutic gain. No tools for a bio-mathematical evaluation of a given degree of interaction for more than two anti-neoplastic agents are currently available. The present work introduces a new method for an evaluation of triple therapies and provides some graphical examples in order to visualize the results.
format Text
id pubmed-1634864
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16348642006-11-08 Isobologram analysis of triple therapies Niyazi, Maximilian Belka, Claus Radiat Oncol Methodology New concepts in radiation oncology are based on the concept that combinations of irradiation and molecular targeted drugs can yield synergistic or at least additive effects. Up to now the combination of two treatment modalities has been tested in almost all cases. Similar to conventional anti-cancer agents, the efficacy of targeted approaches is also subject to predefined resistance mechanisms. Therefore, it seems reasonable to speculate that a combination of more than two agents will ultimately increase the therapeutic gain. No tools for a bio-mathematical evaluation of a given degree of interaction for more than two anti-neoplastic agents are currently available. The present work introduces a new method for an evaluation of triple therapies and provides some graphical examples in order to visualize the results. BioMed Central 2006-10-17 /pmc/articles/PMC1634864/ /pubmed/17044920 http://dx.doi.org/10.1186/1748-717X-1-39 Text en Copyright © 2006 Niyazi and Belka; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Niyazi, Maximilian
Belka, Claus
Isobologram analysis of triple therapies
title Isobologram analysis of triple therapies
title_full Isobologram analysis of triple therapies
title_fullStr Isobologram analysis of triple therapies
title_full_unstemmed Isobologram analysis of triple therapies
title_short Isobologram analysis of triple therapies
title_sort isobologram analysis of triple therapies
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634864/
https://www.ncbi.nlm.nih.gov/pubmed/17044920
http://dx.doi.org/10.1186/1748-717X-1-39
work_keys_str_mv AT niyazimaximilian isobologramanalysisoftripletherapies
AT belkaclaus isobologramanalysisoftripletherapies